Fast-growing telemedicine service provider Teladoc took the first step toward an initial public offering, filing a draft registration statement with the Securities and Exchange Commission, the company said Tuesday.
According to Teladoc, the form S-1 was submitted confidentially, so the company did not have any details to share. A search on the SEC’s website turned up no S-1 from Teladoc and no filings since September, when the Dallas-based telemedicine firm announced that it had raised $50.2 million in new, private investment.
Teladoc CEO Jason Gorevic told MedCity News around the same time that he had not ruled out taking the company public. Gorevic also said that he expected to begin telepsychiatry and teledermatology services by mid-2015. That expansion has not happened yet.
This month, Teladoc fought the Texas Medical Board’s decision to restrict the practice of telemedicine in the Lone Star State. The regulatory board voted to ban Texas physicians from making diagnoses or prescribing drugs via telephone or the Internet for any patient they do not have a previously existing, in-person relationship with.
In reporting on the Texas Medical Board’s ruling, the Dallas Business Journal said Teladoc had 10 million registered users nationwide, including 2.4 million in its home state.
A Teladoc spokesperson did not immediately respond to a request for further information.
